Cargando…
Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer
BACKGROUND: Radiation pneumonitis (RP) is the primary dose-limiting toxicity associated with radiotherapy. This study aimed to observe the effects of renin-angiotensin system inhibitors in Chinese patients with lung cancer who received thoracic radiation. METHODS: Patients with lung cancer who recei...
Autores principales: | Zheng, Yawen, Cong, Changsheng, Wang, Zewen, Liu, Yanan, Zhang, Mingyan, Zhou, Hao, Su, Chen, Sun, Meili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602779/ https://www.ncbi.nlm.nih.gov/pubmed/37901395 http://dx.doi.org/10.3389/fmed.2023.1255786 |
Ejemplares similares
-
Renin-angiotensin system inhibitors mitigate radiation pneumonitis by activating ACE2-angiotensin-(1–7) axis via NF-κB/MAPK pathway
por: Cong, Changsheng, et al.
Publicado: (2023) -
Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer
por: Inoo, Hiroyuki, et al.
Publicado: (2022) -
Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022) -
Angiotensin-converting Enzyme Inhibitors Decrease the Incidence of Radiation-induced Pneumonitis Among Lung Cancer Patients: A Systematic Review and Meta-analysis
por: Sun, Fengze, et al.
Publicado: (2018) -
Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)